Zusduri savings card: as little as $50 a dose with commercial insurance

How to pay the least

Ask for the cash price

Zusduri

The FDA has approved a generic, but it isn’t in pharmacies yet.

Ask your pharmacy for Zusduri’s cash price, and one or two other pharmacies too.
Zusduri’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameZusduri

Authorized genericmitomycin

Regular genericmitomycin

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNot in stores yet

Same as Zusduri?

The original

–

Brand nameThe maker’s card

UroGen Support Copay Program

Savings card from UroGen Pharma

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $50 a dose

The card takes up to $14,000 a year off your co-pay.

Or call 1-888-793-9355.

In the maker’s words

“You may qualify for the UroGen Support™ Copay Program. If you are eligible, you will pay as little as $50 for each dose with a maximum benefit of $14,000/year.”

From the maker’s offer on zusduri.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Zusduri itself, from the same company, sold without the brand name, and usually for less. For now Zusduri is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

The FDA has approved a generic, but it isn’t in pharmacies yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Recurring low-grade bladder cancer (not muscle-invasive)

What the FDA label says

ZUSDURI is an alkylating drug indicated for the treatment of adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Source: the FDA label for Zusduri (UroGen Pharma, Inc), June 20, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/zusduri/